Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 11536198)

Published in J Neurobiol on October 01, 2001

Authors

R M Wolf1, J J Wilkes, M V Chao, M D Resh

Author Affiliations

1: Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.

Articles citing this

Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. PLoS Biol (2007) 1.92

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain (2009) 1.49

Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol (2004) 1.47

p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev (2003) 1.16

Myosin II has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol (2008) 1.14

The function of RhoGTPases in axon ensheathment and myelination. Glia (2008) 1.06

SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion. Mol Cell Biol (2010) 1.04

Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination. Mol Biol Cell (2015) 1.00

Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination. J Biol Chem (2009) 0.99

Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation. Glia (2011) 0.98

Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res (2012) 0.93

Integrin α3 is required for late postnatal stability of dendrite arbors, dendritic spines and synapses, and mouse behavior. J Neurosci (2013) 0.93

Regulation of adherens junction dynamics by phosphorylation switches. J Signal Transduct (2012) 0.92

Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination. PLoS One (2012) 0.89

MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination. J Cell Sci (2011) 0.87

Pituitary adenylate cyclase-activating polypeptide 38-mediated Rin activation requires Src and contributes to the regulation of HSP27 signaling during neuronal differentiation. Mol Cell Biol (2008) 0.87

Integrin signaling in oligodendrocytes and its importance in CNS myelination. J Signal Transduct (2010) 0.87

Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res (2011) 0.87

Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation. Mol Biol Cell (2010) 0.86

Slit2 regulates the dispersal of oligodendrocyte precursor cells via Fyn/RhoA signaling. J Biol Chem (2012) 0.84

Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development. Dev Dyn (2013) 0.83

RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury. Exp Neurol (2011) 0.81

A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility. BMC Neurosci (2016) 0.78

Altered gene expression in the adult brain of fyn-deficient mice. Cell Mol Neurobiol (2004) 0.78

Oligodendrocytes in a Nutshell. Front Cell Neurosci (2015) 0.77

MKK6 phosphorylation regulates production of superoxide by enhancing Rac GTPase activity. Antioxid Redox Signal (2007) 0.77

Role of pleiotrophin-protein tyrosine phosphatase receptor type Z signaling in myelination. Neural Regen Res (2016) 0.76

Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity: PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION. J Biol Chem (2016) 0.75

Articles by these authors

Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol (1994) 6.67

Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 6.26

Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46

High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (1991) 4.44

Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol (2001) 4.09

Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell (1992) 3.91

The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (1991) 3.86

Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60

Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol (2000) 3.54

Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol (1996) 3.19

Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem (2000) 3.18

Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol (2001) 2.82

The regulated expression of beta-globin genes introduced into mouse erythroleukemia cells. Cell (1983) 2.75

The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48

Highly specific antibody to Rous sarcoma virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules. J Cell Biol (1985) 2.32

Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side. Nature (1978) 2.27

Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (1996) 2.14

Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc Natl Acad Sci U S A (1994) 2.12

Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates. J Virol (2000) 2.11

Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci (1998) 2.06

Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05

Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol (1997) 2.03

K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem (1992) 2.01

Membrane binding of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry (1994) 1.99

Gene transfer and molecular cloning of the human NGF receptor. Science (1986) 1.91

Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization. J Biol Chem (1994) 1.90

Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A (2001) 1.85

Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2. J Biol Chem (1990) 1.82

Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins. J Biol Chem (1995) 1.79

Electrostatics and the membrane association of Src: theory and experiment. Biochemistry (1998) 1.78

In vitro synthesis of pp60v-src: myristylation in a cell-free system. Mol Cell Biol (1988) 1.77

Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res (1988) 1.72

Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science (1994) 1.71

Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J Virol (1996) 1.70

DNA sequence directs placement of histone cores on restriction fragments during nucleosome formation. Biochemistry (1979) 1.69

GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell (2001) 1.65

Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem (2001) 1.63

Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol (1999) 1.62

Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol Biol Cell (1997) 1.59

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest (1999) 1.58

Association of the p75 neurotrophin receptor with TRAF6. J Biol Chem (1999) 1.56

Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci (2001) 1.53

Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src. J Cell Biol (1992) 1.53

Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci U S A (1993) 1.51

p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J Biol Chem (1995) 1.48

Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48

High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem (1994) 1.48

The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell (1991) 1.47

Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol (1999) 1.45

An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J Neurosci (2001) 1.33

The structure of the thymidine kinase gene promoter: nuclease hypersensitivity correlates with expression. Cell (1982) 1.30

Mesenchymal and neuronal cell expression of the p75 neurotrophin receptor gene occur by different mechanisms. Dev Biol (1995) 1.28

p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron (1994) 1.28

The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem (2001) 1.25

Expression of functional nerve growth factor receptors after gene transfer. Science (1989) 1.25

Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development (1999) 1.23

Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src. J Biol Chem (1993) 1.22

p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep (2001) 1.20

Brain-specific src oncogene mRNA mapped in rat brain by in situ hybridization. Proc Natl Acad Sci U S A (1988) 1.17

A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem (1997) 1.17

Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions. J Cell Biol (1999) 1.16

Synthesis and use of iodo-fatty acid analogs. Methods Enzymol (1995) 1.16

The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A (1991) 1.15

Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ (1998) 1.14

A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci (2001) 1.14

Development of insulin responsiveness of the glucose transporter and the (Na+,K+)-adenosine triphosphatase during in vitro adipocyte differentiation. J Biol Chem (1982) 1.13

Chimeric NGF-EGF receptors define domains responsible for neuronal differentiation. Science (1991) 1.12

Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J Mol Biol (1998) 1.11

TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol (2000) 1.10

Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. J Biol Chem (1994) 1.10

Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. J Neurobiol (1998) 1.10

The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol (2001) 1.09

A potential interaction of p75 and trkA NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res (1995) 1.08

Neurotrophins in cell survival/death decisions. Adv Exp Med Biol (1999) 1.08

Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain. Proc Natl Acad Sci U S A (1987) 1.07

Activation of mitogen-activated protein kinase by membrane-targeted Raf chimeras is independent of raft localization. J Biol Chem (2001) 1.06

Deletion of cytoplasmic sequences of the nerve growth factor receptor leads to loss of high affinity ligand binding. J Biol Chem (1990) 1.06

DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia. Mol Biol Med (1986) 1.04

HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci (1993) 1.04

Nerve growth factor production by lymphocytes. J Immunol (1994) 1.03

lac Operator nucleosomes. 2. lac Nucleosomes can change conformation to strengthen binding by lac repressor. Biochemistry (1980) 1.03

Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene (2010) 1.02

Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor. Proc Natl Acad Sci U S A (1999) 1.01

Nerve growth factor stimulates the hydrolysis of glycosylphosphatidylinositol in PC-12 cells: a mechanism of protein kinase C regulation. Proc Natl Acad Sci U S A (1989) 1.01

Mechanisms of neurotrophin receptor signalling. Biochem Soc Trans (2006) 1.00

Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron (1995) 0.99

Acylation and prenylation of proteins. Curr Opin Cell Biol (1990) 0.98

Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain. Proc Natl Acad Sci U S A (1996) 0.98

Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res (2000) 0.98

Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci (1999) 0.98

Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A (1988) 0.98

Apoptotic signaling through the beta -adrenergic receptor. A new Gs effector pathway. J Biol Chem (2000) 0.97

Quantitation and characterization of the (Na+,K+)-adenosine triphosphatase in the rat adipocyte plasma membrane. J Biol Chem (1982) 0.97

Structural determinants of neurotrophin action. J Biol Chem (1995) 0.97

p75 neurotrophin receptor as a modulator of survival and death decisions. Microsc Res Tech (1999) 0.96

Fatty acyl transfer by human N-myristyl transferase is dependent upon conserved cysteine and histidine residues. J Biol Chem (1994) 0.96

Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods Enzymol (2000) 0.96

BRE: a modulator of TNF-alpha action. FASEB J (1998) 0.95

TNF-related ligands and their receptors. Cell Signal (1998) 0.95